首页> 美国卫生研究院文献>Journal of Medical Case Reports >Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1 6 and 13: a case report
【2h】

Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1 6 and 13: a case report

机译:儿童易位t(1; 19)(q21.1; p13.3)的B前急性淋巴细胞性白血病和另外两个涉及染色体1、6和13的染色体畸变:一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe translocation t(1;19)(q23;p13), which results in the TCF3-PBX1 chimeric gene, is one of the most frequent rearrangements observed in B cell acute lymphoblastic leukemia. It appears in both adult and pediatric patients with B cell acute lymphoblastic leukemia at an overall frequency of 3 to 5%. Most cases of pre-B cell acute lymphoblastic leukemia carrying the translocation t(1;19) have a typical immunophenotype with homogeneous expression of CD19, CD10, CD9, complete absence of CD34, and at least diminished CD20. Moreover, the translocation t(1;19) correlates with known clinical high risk factors, such as elevated white blood cell count, high serum lactate dehydrogenase levels, and central nervous system involvement; early reports indicated that patients with translocation t(1;19) had a poor outcome under standard treatment.
机译:背景易位t(1; 19)(q23; p13)是TCF3-PBX1嵌合基因,是B细胞急性淋巴细胞白血病中最常见的重排之一。在成人和小儿患有B细胞急性淋巴细胞白血病的患者中,总发生率为3%至5%。携带易位t(1; 19)的大多数B前细胞急性淋巴细胞白血病病例具有典型的免疫表型,CD19,CD10,CD9均表达,完全不存在CD34,并且至少减少了CD20。此外,易位t(1; 19)与已知的临床高危因素相关,例如白细胞计数升高,血清乳酸脱氢酶水平高和中枢神经系统受累。早期报道表明,在标准治疗下,t(1; 19)易位的患者预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号